|
1
|
Hirbod-Mobarakeh A, Gordan HA, Zahiri Z,
Mirshahvalad M, Hosseinverdi S, Rini BI and Rezaei N: Specific
immunotherapy in renal cancer: A systematic review. Ther Adv Urol.
9:45–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Turajlic S, Larkin J and Swanton C:
SnapShot: Renal cell carcinoma. Cell. 163:1556–1556.e1. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ling S, Nheu L and Komesaroff PA: Cell
adhesion molecules as pharmaceutical target in atherosclerosis.
Mini Rev Med Chem. 12:175–183. 2012. View Article : Google Scholar
|
|
4
|
Mazza C, Escudier B and Albiges L:
Nivolumab in renal cell carcinoma: Latest evidence and clinical
potential. Ther Adv Med Oncol. 9:171–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thakor P, Song W, Subramanian RB, Thakkar
VR, Vesey DA and Gobe GC: Maslinic acid inhibits proliferation of
renal cell carcinoma cell lines and suppresses angiogenesis of
endothelial cells. J Kidney Cancer VHL. 4:16–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heng DY: The next 10 years: Challenges for
the future and overcoming resistance to targeted therapies for
renal cell carcinoma. Can Urol Assoc J. 10(11-12 Suppl 7):
S256–S258. 2016. View Article : Google Scholar
|
|
7
|
Lim SH, Hwang IG, Ji JH, Oh SY, Yi JH, Lim
DH, Lim HY, Lee SJ and Park SH: Intrinsic resistance to sunitinib
in patients with metastatic renal cell carcinoma. Asia Pac J Clin
Oncol. 13:61–67. 2017. View Article : Google Scholar
|
|
8
|
Santoso S, Sachs UJ, Kroll H, Linder M,
Ruf A, Preissner KT and Chavakis T: The junctional adhesion
molecule 3 (JAM-3) on human platelets is a counterreceptor for the
leukocyte integrin Mac-1. J Exp Med. 196:679–691. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galkina E and Ley K: Vascular adhesion
molecules inatherosclerosis. Arterioscler Thromb Vasc Biol.
27:2292–2301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yin A, Zhang Q, Kong X, Jia L, Yang Z,
Meng L, Li L, Wang X, Qiao Y, Lu N, et al: JAM3 methylation status
as a biomarker for diagnosis of preneoplastic and neoplastic
lesions of the cervix. Oncotarget. 6:44373–44387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gurzu S, Silveanu C, Fetyko A, Butiurca V,
Kovacs Z and Jung I: Systematic review of the old and new concepts
in the epithelial-mesenchymal transition of colorectal cancer.
World J Gastroenterolog. 22:6764–6775. 2016. View Article : Google Scholar
|
|
12
|
Song Y, Wang L, Yang F, Wu X, Duan Q and
Gong Z: Increased expressions of integrin subunit β1, β2 and β3 in
patients with acute infection. Int J Med Sci. 12:639–643. 2015.
View Article : Google Scholar :
|
|
13
|
Zheng B, Zhu H, Gu D, Pan X, Qian L, Xue
B, Yang D, Zhou J and Shan Y: MiRNA-30a-mediated autophagy
inhibition sensitizes renal cell carcinoma cells to sorafenib.
Biochem Biophys Res Commun. 459:234–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng B, Mao JH, Qian L, Zhu H, Gu DH, Pan
XD, Yi F and Ji DM: Pre-clinical evaluation of AZD-2014, a
novelmTORC1/2 dual inhibitor, against renal cell carcinoma. Cancer
Lett. 357:468–475. 2015. View Article : Google Scholar
|
|
15
|
Zheng B, Mao JH, Li XQ, Qian L, Zhu H, Gu
DH and Pan XD: Overexpression of DNA-PKcs in renal cell
carcinomaregulates mTORC2 activation, HIF-2alpha expression and
cell proliferation. Sci Rep. 6:294152016. View Article : Google Scholar
|
|
16
|
Wu D, Ding J, Wang L, Pan H, Zhou Z, Zhou
J and Qu P: microRNA-125b inhibits cell migration and invasion
bytargeting matrix metallopeptidase 13 in bladder cancer. Oncol
Lett. 5:829–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Mook OR, Frederiks WM and Van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophysica Acta. 1705:69–89. 2004.
|
|
19
|
Su NW, Wu SH, Chi CW, Liu CJ, Tsai TH and
Chen YJ: Metronomic cordycepin therapy prolongs survival of oral
cancer-bearing mice and inhibits epithelial-mesenchymal transition.
Molecules. 22:E6292017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsubara M and Bissell MJ: Inhibitors of
Rho kinase (ROCK) signaling revert the malignant phenotype of
breast cancer cells in 3D context. Oncotarge. 7:31602–31622. 2016.
View Article : Google Scholar
|
|
21
|
Moroz A, Delella FK, Lacorte LM, Deffune E
and Felisbino SL: Fibronectin induces MMP2 expression in human
prostate cancer cells. Biochem Biophys Res Commun. 430:1319–1321.
2013. View Article : Google Scholar
|
|
22
|
Motzer RJ, Hutson TE, Cella D, Reeves J,
Hawkins R, Guo J, Nathan P, Staehler M, de Souza P, Merchan JR, et
al: Pazopanib versus sunitinibin metastatic renal-cell carcinoma. N
Engl J Med. 369:722–731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fiori E, De Cesare A, Galati G, Bononi M,
D'Andrea N, Barbarosos A, Izzo L and Bolognese A: Prognostic
significanceof primary-tumor extension, stage and grade of
nucleardifferentiation in patients with renal cell carcinoma. J Exp
Clin Cancer Res. 21:229–232. 2002.PubMed/NCBI
|
|
28
|
Uygur MC, Usubütün A, Ozen H, Ayhan A and
Kendi S: Prognosticfactors and the role of nephrectomy in
metastatic renal cellcarcinoma. J Exp Clin Cancer Res. 18:397–401.
1999.PubMed/NCBI
|
|
29
|
Amato RJ: Chemotherapy for renal cell
carcinoma. Semin Oncol. 27:177–186. 2000.PubMed/NCBI
|
|
30
|
Ljungberg B, Cowan NC, Hanbury DC, Hora M,
Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF and Sinescu IC;
European Association of Urology Guideline Group: EAU guidelines on
renal cell carcinoma: The 2010 update. Eur Urol. 58:398–406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dutcher JP and Nanus D: Long-term survival
of patients with sarcomatoid renal cell cancer treated with
chemotherapy. Med Oncol. 28:1530–1533. 2011. View Article : Google Scholar
|
|
32
|
Hajjari M, Behmanesh M, Sadeghizadeh M and
Zeinoddini M: Junctional adhesion molecules 2 and 3 may potentially
be involved in progression of gastric adenocarcinoma tumors. Med
Oncol. 30:3802013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vonlaufen A, Aurrand-Lions M, Pastor CM,
Lamagna C, Hadengue A, Imhof BA and Frossard JL: The role of
junctional adhesion molecule C (JAM-C) in acute pancreatitis. J
Pathol. 209:540–548. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Phan RT and Dalla-Favera R: The BCL6
proto-oncogene suppresses p53 expression in germinal-centre B
cells. Nature. 432:635–639. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ebnet K, Aurrand-Lions M, Kuhn A, Kiefer
F, Butz S, Zander K, Meyer zu Brickwedde MK, Suzuki A, Imhof BA and
Vestweber D: The junctional adhesion molecule (JAM) family members
JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: A
possible role for JAMs in endothelial cell polarity. J Cell Sci.
116:3879–3891. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ebnet K, Suzuki A, Ohno S and Vestweber D:
Junctional adhesion molecules (JAMs): More molecules with dual
functions. J Cell Sci. 117:19–29. 2004. View Article : Google Scholar
|
|
37
|
Li J, Ballif BA, Powelka AM, Dai J, Gygi
SP and Hsu VW: Phosphorylation of ACAP1 by Akt regulates the
stimulation-dependent recycling of integrin beta1 to control cell
migration. Dev Cell. 9:663–673. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dai J, Li J, Bos E, Porcionatto M, Premont
RT, Bourgoin S, Peters PJ and Hsu VW: ACAP1 promotes endocytic
recycling by recognizing recycling sorting signals. Dev Cell.
7:771–776. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sato K, Shirai R, Hontani M, Shinooka R,
Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R,
Matsuyama TA, et al: Potent vasoconstrictor kisspeptin-10 induces
atherosclerotic plaque progression and instability: Reversal by its
receptor GPR54 antagonist. J Am Heart Assoc. 6:e0057902017.
View Article : Google Scholar : PubMed/NCBI
|
